- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CWQ: 2-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl-(8-oxidanylquinolin-2-yl)carbonyl-amino]ethyl-dimethyl-azanium(Non-covalent)
CWQ.7: 16 residues within 4Å:- Chain A: H.372, Y.373, D.375, V.377, Q.517, Q.518
- Chain B: I.462, L.463, S.466, N.485, N.486, N.504, E.506, S.507, T.508
- Ligands: EDO.23
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:H.372, A:V.377, A:Q.517, A:Q.518, B:I.462, B:L.463, B:T.508
- Water bridges: A:Q.518
- Salt bridges: A:D.375
- pi-Stacking: A:Y.373
- Hydrogen bonds: B:T.508
CWQ.8: 17 residues within 4Å:- Chain A: I.69, D.70, W.82, G.116, G.117, T.120, E.197, S.198, W.231, P.285, L.286, V.288, A.328, F.329, Y.332, F.398, H.438
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:D.70, A:T.120, A:V.288, A:F.329, A:F.329, A:Y.332, A:F.398
- Hydrogen bonds: A:H.438
- Salt bridges: A:D.70, A:E.197
- pi-Stacking: A:W.231, A:W.231, A:F.329
CWQ.20: 16 residues within 4Å:- Chain A: I.462, L.463, S.466, N.485, N.486, N.504, E.506, S.507, T.508
- Chain B: H.372, Y.373, D.375, V.377, Q.517, Q.518
- Ligands: EDO.14
10 PLIP interactions:6 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:H.372, B:V.377, B:Q.517, B:Q.518, A:I.462, A:L.463, A:T.508
- Salt bridges: B:D.375
- pi-Stacking: B:Y.373
- Hydrogen bonds: A:T.508
CWQ.21: 17 residues within 4Å:- Chain B: N.68, I.69, D.70, W.82, G.116, G.117, T.120, E.197, S.198, W.231, L.286, S.287, V.288, A.328, F.329, Y.332, H.438
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:D.70, B:T.120, B:V.288, B:A.328, B:F.329, B:Y.332
- Hydrogen bonds: B:T.120, B:H.438
- Salt bridges: B:D.70, B:E.197
- pi-Stacking: B:W.231, B:W.231, B:F.329
- pi-Cation interactions: B:Y.332
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 1 residues within 4Å:- Chain A: R.135
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.135, A:R.135
GOL.10: 3 residues within 4Å:- Chain A: K.513, A.516, R.520
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.513
GOL.11: 6 residues within 4Å:- Chain A: P.189, K.190, S.215, F.217, T.218, K.313
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.190, A:S.215, A:K.313, A:K.313
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.12: 4 residues within 4Å:- Chain A: H.77, M.81, E.443, Y.456
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.456
- Water bridges: A:K.427
EDO.13: 6 residues within 4Å:- Chain A: L.18, L.29, Y.61, W.98, D.129, K.131
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.98, A:K.131
EDO.14: 7 residues within 4Å:- Chain A: S.466, R.470, S.487, T.488, L.503, T.508
- Ligands: CWQ.20
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.466, A:R.470, A:T.488, A:T.508
EDO.23: 6 residues within 4Å:- Chain B: S.466, R.470, S.487, T.488, T.508
- Ligands: CWQ.7
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.466, B:R.470, B:T.488
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.15: 3 residues within 4Å:- Chain A: N.106, N.188, K.190
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:N.106
- Hydrogen bonds: A:N.188
- Water bridges: A:K.190
NAG.16: 4 residues within 4Å:- Chain A: R.465, K.469, E.482, N.485
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:K.469
- Hydrogen bonds: A:N.485
NAG.24: 2 residues within 4Å:- Chain B: R.14, N.57
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.14, B:N.57
NAG.25: 4 residues within 4Å:- Chain B: R.465, K.469, E.482, N.485
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.465, B:N.485
- 5 x SO4: SULFATE ION(Non-functional Binders)
SO4.17: 4 residues within 4Å:- Chain A: Q.316, G.413, N.414, N.415
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.316, A:N.414, A:N.415
SO4.18: 4 residues within 4Å:- Chain A: A.62, N.63, D.91, Y.94
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.63, A:D.91
SO4.19: 7 residues within 4Å:- Chain A: P.230, W.231, V.233, T.234, E.238, R.242, V.288
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:V.288, A:V.288
- Salt bridges: A:R.242
SO4.26: 6 residues within 4Å:- Chain B: P.230, W.231, T.234, E.238, R.242, V.288
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:V.233
- Salt bridges: B:R.242
SO4.27: 4 residues within 4Å:- Chain B: Q.316, G.413, N.414, N.415
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Q.316, B:G.413, B:N.414, B:N.415
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knez, D. et al., Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Eur.J.Med.Chem. (2018)
- Release Date
- 2018-09-05
- Peptides
- Cholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CWQ: 2-[[(3~{R})-1-(2,3-dihydro-1~{H}-inden-2-yl)piperidin-3-yl]methyl-(8-oxidanylquinolin-2-yl)carbonyl-amino]ethyl-dimethyl-azanium(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x SO4: SULFATE ION(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knez, D. et al., Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Eur.J.Med.Chem. (2018)
- Release Date
- 2018-09-05
- Peptides
- Cholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B